Crossing these mice with transgenic mice overexpressing HER2 in the mammary gland led to the suppression of mammary tumorigenesis, supporting the evidence that abrogating the inhibitory effect of HER2 in autophagy leads to the inhibition of tumor formation [68]. This evidence concerns the gene ERBB2 and neoplasm.